Korea CDC and IVI seek cooperation on vaccine research to tackle infectious diseases
Two organizations will cooperate on joint vaccine research and scientific exchange
- To collaborate in vaccine research against emerging infectious diseases such as Zika virus
- To share technology and know-how in vaccine development
- To engage in scientific exchange to nurture human resources for vaccine development
Dr. Jung Ki-Suck, Director of the Korea Center for Disease Control and Prevention (KCDC) visited the International Vaccine Institute (IVI) and met with IVI’s Director General Dr. Jerome Kim on April 15, where the two organizations discussed mutual cooperation in research efforts, including the development of a vaccine against the Zika virus, and in managing and responding to public health crises such as emerging infectious diseases. In addition, the two organizations agreed to cooperate in exchange of human resources to nurture and train professionals in vaccine development in South Korea.
“At a time when infectious diseases such as Zika are emerging, research cooperation with an organization like IVI, which has experience and expertise in vaccine development, is important,” said Dr. Jung, “I propose an exchange and sharing of technology and know-how in vaccine development between KCDC and IVI.”
IVI was the first International Organization hosted by South Korea. Established in 1997 at the initiative of the United Nations Development Program to develop and introduce vaccines for the developing world, it is supported by the South Korean government. South Korea is also a signatory to IVI’s treaty, which includes 35 others signatories such as Sweden and the World Health Organization. This is the first collaboration between IVI and the KCDC.
“IVI is very pleased to collaborate with KCDC on vaccine research and training initiatives,” said Dr. Jerome Kim, “This collaboration will mutually benefit the two organizations, Korea’s vaccine R&D, and ultimately improve the health and wellbeing of people in South Korea and worldwide.”